{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:10:08Z","timestamp":1772820608421,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011699","name":"Siemens Healthineers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.radonc.2025.111089","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:49:15Z","timestamp":1754750955000},"page":"111089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3919-5135","authenticated-orcid":false,"given":"A.","family":"Corbeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Astreinidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-6749","authenticated-orcid":false,"given":"S.C.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8848-3451","authenticated-orcid":false,"given":"P.A.","family":"Wielopolski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.M.","family":"Mens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-9604","authenticated-orcid":false,"given":"H.","family":"Westerveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Donker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-3407","authenticated-orcid":false,"given":"L.A.","family":"Velema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2671-1903","authenticated-orcid":false,"given":"J.R.","family":"Kroep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-6346","authenticated-orcid":false,"given":"I.A.","family":"Boere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-8266","authenticated-orcid":false,"given":"M.J.P.","family":"Welters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4264-9903","authenticated-orcid":false,"given":"M.S.","family":"Hoogeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Putter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Godart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.A.","family":"van der Heide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111089_b0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13014-020-01606-3","article-title":"Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial","volume":"15","author":"Huang","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0010","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2009.12.025","article-title":"Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow\u2013sparing pelvic IMRT","volume":"79","author":"Albuquerque","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111089_b0015","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.2147\/CMAR.S195989","article-title":"Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation","author":"Kumar","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.radonc.2025.111089_b0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2021.08.019","article-title":"Positron emission tomography-guided bone marrow-sparing radiation therapy for locoregionally advanced cervix cancer: final results from the INTERTECC phase II\/III trial","volume":"112","author":"Williamson","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111089_b0025","article-title":"Predictors of Acute Hematologic Toxicity in Women receiving extended-field chemoradiation for cervical Cancer: do known pelvic Radiation bone marrow constraints apply?","volume":"7","author":"Hara","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0030","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1002\/cam4.2601","article-title":"The volume of 99mTc sulfur colloid SPET\u2010defined active bone marrow can predict grade 3 or higher acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2025.111089_b0035","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.34771","volume":"129","author":"Wang","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111089_b0040","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111089_b0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2015.11.013","article-title":"Lymphopenia and its association with survival in patients with locally advanced cervical cancer","volume":"140","author":"Wu","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2025.111089_b0055","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2025.111089_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00020","article-title":"T Cells and cancer: how metabolism shapes immunity","volume":"7","author":"Molon","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2025.111089_b0065","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111089_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00066-022-02007-z","article-title":"Influence of chemoradiation on the immune microenvironment of cervical cancer patients","volume":"199","author":"Herter","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111089_b0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphar.2018.00185","article-title":"Combining immunotherapy and radiotherapy for cancer treatment: current challenges and future directions","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.radonc.2025.111089_b0080","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s12094-020-02345-3","article-title":"Radiation-induced lymphopenia: the main aspects to consider in immunotherapy trials for endometrial and cervical cancer patients","volume":"22","author":"Holub","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0085","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.111089_b0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1088\/0031-9155\/5\/3\/302","article-title":"The distribution of active bone marrow in the adult","volume":"5","author":"Ellis","year":"1961","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111089_b0095","first-page":"397","article-title":"Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury","volume":"2","author":"Shao","year":"2013","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.radonc.2025.111089_b0100","first-page":"391","article-title":"The ultrastructure of the hemopoietic environment of the marrow: a review","volume":"9","author":"Lichtman","year":"1981","journal-title":"Exp Hematol"},{"key":"10.1016\/j.radonc.2025.111089_b0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ncb3570","article-title":"Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF","volume":"19","author":"Zhou","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.radonc.2025.111089_b0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2014.02.018","article-title":"Consequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors","volume":"63","author":"Green","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.radonc.2025.111089_b0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13287-024-03853-7","article-title":"Insights into ionizing radiation-induced bone marrow hematopoietic stem cell injury","volume":"15","author":"Zhang","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.radonc.2025.111089_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064952","article-title":"Altered composition of bone as triggered by irradiation facilitates the rapid erosion of the matrix by both cellular and physicochemical processes","volume":"8","author":"Green","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2025.111089_b0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","article-title":"Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment","volume":"460","author":"Naveiras","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2025.111089_b0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13014-022-02029-y","article-title":"Correlation between changes of pelvic bone marrow fat content and hematological toxicity in concurrent chemoradiotherapy for cervical cancer","volume":"17","author":"Wang","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0135","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/jmri.24071","article-title":"Water\u2013fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients","volume":"38","author":"Bolan","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2025.111089_b0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijrobp.2014.05.041","article-title":"Fat composition changes in bone marrow during chemotherapy and radiation therapy","volume":"90","author":"Carmona","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111089_b0145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1186\/s12885-022-10254-7","article-title":"Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer","volume":"22","author":"Qin","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111089_b0150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radmp.2023.08.002","article-title":"Association between IDEAL-IQ MRI fat fraction quantification and pelvic bone marrow reserve function in concurrent chemoradiotherapy for cervical cancer","volume":"4","author":"Wen","year":"2023","journal-title":"Radiat Med Prot"},{"key":"10.1016\/j.radonc.2025.111089_b0155","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.3390\/cancers13205179","article-title":"PROTECT: prospective Phase-II-Trial evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System","volume":"13","author":"Corbeau","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.111089_b0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ctro.2018.01.001","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clinical and translational radiation oncology"},{"key":"10.1016\/j.radonc.2025.111089_b0165","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.111089_b0170","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2021.09.009","article-title":"Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review","volume":"164","author":"Corbeau","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1138433","article-title":"The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis","volume":"13","author":"Kuipers","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0180","article-title":"Accuracy, repeatability, and reproducibility of water-fat magnetic resonance imaging in a phantom and healthy volunteer","volume":"32","author":"Corbeau","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0185","unstructured":"Health UDo, Services H. Common terminology criteria for adverse events (CTCAE) version 5.0. 2017."},{"key":"10.1016\/j.radonc.2025.111089_b0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2016.04.009","article-title":"Using [18F]Fluorothymidine Imaged with Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity due to Chemoradiation Therapy for Pelvic Cancer patients","volume":"96","author":"McGuire","year":"2016","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.111089_b0195","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2010.12.009","article-title":"3\u2019-deoxy-3\u2019-[18F] fluorothymidine PET quantification of bone marrow response to radiation dose","volume":"81","author":"McGuire","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111089_b0200","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/jmri.26748","article-title":"Proton density fat fraction MRI of vertebral bone marrow: Accuracy, repeatability, and reproducibility among readers, field strengths, and imaging platforms","volume":"50","author":"Schmeel","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2025.111089_b0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/RLI.0000000000000561","article-title":"Agreement and Reproducibility of Proton Density Fat Fraction Measurements using Commercial MR Sequences across Different Platforms: a Multivendor, Multi-Institutional Phantom Experiment","volume":"54","author":"Jang","year":"2019","journal-title":"Invest Radiol"},{"key":"10.1016\/j.radonc.2025.111089_b0210","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jmri.24854","article-title":"Assessment of whole spine vertebral bone marrow fat using chemical shift-encoding based water-fat MRI","volume":"42","author":"Baum","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2025.111089_b0215","article-title":"Validation of quantitative magnetic resonance imaging techniques in head and neck healthy structures involved in the salivary and swallowing function: Accuracy and repeatability. Phys Imaging","volume":"31","author":"Guerreiro","year":"2024","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0220","doi-asserted-by":"crossref","first-page":"e1465","DOI":"10.1210\/clinem\/dgad355","article-title":"The Multifaceted Roles of Bone Marrow Adipocytes in Bone and Hematopoietic Homeostasis","volume":"108","author":"Li","year":"2023","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.radonc.2025.111089_b0225","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.stem.2017.02.009","article-title":"Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration","volume":"20","author":"Ambrosi","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.radonc.2025.111089_b0230","article-title":"Lipolysis of bone marrow adipocytes is required to fuel bone and the marrow niche during energy deficits","volume":"11","author":"Li","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.radonc.2025.111089_b0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/joim.12718","article-title":"Clinical implications of bone marrow adiposity","volume":"283","author":"Veldhuis-Vlug","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.radonc.2025.111089_b0240","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150538","article-title":"Quantification of bone marrow fat content using iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): reproducibility, site variation and correlation with age and menopause","volume":"89","author":"Aoki","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.111089_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00141","article-title":"Anatomical Variation of Age-Related changes in Vertebral Bone Marrow Composition using Chemical Shift Encoding-based Water\u2013Fat magnetic Resonance Imaging","volume":"9","author":"Baum","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.radonc.2025.111089_b0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ni1033","article-title":"Age-related changes in lymphocyte development and function","volume":"5","author":"Linton","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.radonc.2025.111089_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.853765","article-title":"The Implications of Bone Marrow Adipose Tissue on Inflammaging","volume":"13","author":"Aaron","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.radonc.2025.111089_b0260","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/cells13090724","article-title":"Bone Marrow Adipose Tissue","volume":"13","author":"Marinelli Busilacchi","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.radonc.2025.111089_b0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11914-018-0424-1","article-title":"Marrow Adiposity and Hematopoiesis in Aging and Obesity: Exercise as an intervention","volume":"16","author":"Patel","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.radonc.2025.111089_b0270","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1120\/jacmp.v15i4.4780","article-title":"Spatial mapping of functional pelvic bone marrow using FLT PET","volume":"15","author":"McGuire","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.111089_b0275","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ijrobp.2016.11.033","article-title":"Longitudinal changes in active Bone Marrow for Cervical Cancer patients Treated with concurrent Chemoradiation Therapy","volume":"97","author":"Noticewala","year":"2017","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.111089_b0280","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7150\/jca.11348","article-title":"Longitudinal FDG-PET Revealed Regional Functional Heterogeneity of Bone Marrow, Site-Dependent Response to Treatment and Correlation with Hematological Parameters","volume":"6","author":"Yagi","year":"2015","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2025.111089_b0285","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.adro.2019.06.005","article-title":"18F-FDG PET Predicts Hematologic Toxicity in patients with locally Advanced Anal Cancer Treated with Chemoradiation","volume":"4","author":"David","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0290","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ijrobp.2014.08.017","article-title":"[18F]FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and late Hematological Toxicity in Cervical Cancer patients Treated with Chemoradiation Therapy","volume":"90","author":"Elicin","year":"2014","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.111089_b0295","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ijrobp.2011.09.048","article-title":"Correlation between Radiation Dose to 18F-FDG-PET Defined active Bone Marrow Subregions and Acute Hematologic Toxicity in Cervical Cancer patients Treated with Chemoradiotherapy","volume":"83","author":"Rose","year":"2012","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.111089_b0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prro.2017.07.001","article-title":"Predicting severe hematologic toxicity from extended-field chemoradiation of para-aortic nodal metastases from cervical cancer","volume":"8","author":"Yan","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0305","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12094-017-1771-6","article-title":"The absolute volume of PET-defined, active bone marrow spared predicts for high grade hematologic toxicity in cervical cancer patients undergoing chemoradiation","volume":"20","author":"Zhou","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0310","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3390\/cancers16101842","article-title":"Hematologic Toxicity and Bone Marrow-Sparing strategies in Chemoradiation for locally Advanced Cervical Cancer: a Systematic Review","volume":"16","author":"Konnerth","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.111089_b0315","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00330-023-10189-y","article-title":"Longitudinal MR-based proton-density fat fraction (PDFF) and T2* for the assessment of associations between bone marrow changes and myelotoxic chemotherapy","volume":"34","author":"Gassert","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2025.111089_b0320","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.adro.2018.08.014","article-title":"Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors","volume":"3","author":"Ellsworth","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111089_b0325","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1667\/RR15367.1","article-title":"Comprehensive analysis of the kinetics of radiation-induced lymphocyte loss in patients treated with external beam radiation therapy","volume":"193","author":"Ellsworth","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2025.111089_b0330","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia Association with Gross Tumor volume and Lung V5 and its Effects on Non-Small Cell Lung Cancer Patient Outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.111089_b0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14338\/IJPT-17-00033.1","article-title":"Lymphocyte-Sparing effect of Proton Therapy in patients with Esophageal Cancer Treated with Definitive Chemoradiation","volume":"4","author":"Fang","year":"2017","journal-title":"International Journal of Particle Therapy"},{"key":"10.1016\/j.radonc.2025.111089_b0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijrobp.2018.01.069","article-title":"Effect of Radiation Treatment volume Reduction on Lymphopenia in patients Receiving Chemoradiotherapy for Glioblastoma","volume":"101","author":"Rudra","year":"2018","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.111089_b0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2022.10.019","article-title":"Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): a systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy","volume":"177","author":"Venkatesulu","year":"2022","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025045931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025045931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:03:36Z","timestamp":1772798616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025045931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":69,"alternative-id":["S0167814025045931"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111089","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111089"}}